These results imply that RhoGDIβ overexpression inhibits miR‐200c abundance, which results in promoting JNK2 protein translation and subsequently upregulating Sp1 activity and mmp‐2 transcription, as well as promoting BC cell invasion. This evidence concerns the gene MAPK9 and breast cancer.